These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 9582084

  • 1. Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.
    Prahalada S, Rhodes L, Grossman SJ, Heggan D, Keenan KP, Cukierski MA, Hoe CM, Berman C, van Zwieten MJ.
    Prostate; 1998 May 15; 35(3):157-64. PubMed ID: 9582084
    [Abstract] [Full Text] [Related]

  • 2. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
    Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS.
    Endocrinology; 1999 Oct 15; 140(10):4509-15. PubMed ID: 10499505
    [Abstract] [Full Text] [Related]

  • 3. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A, Hayashi N, Sugimura Y, Cunha GR, Kawamura J.
    Prostate; 1996 Jul 15; 29(1):1-14. PubMed ID: 8685049
    [Abstract] [Full Text] [Related]

  • 4. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW.
    Endocrinology; 1997 Mar 15; 138(3):871-7. PubMed ID: 9048585
    [Abstract] [Full Text] [Related]

  • 5. Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor.
    Prahalada SR, Keenan KP, Hertzog PR, Gordon LR, Peter CP, Soper KA, van Zwieten MJ, Bokelman DL.
    Urology; 1994 May 15; 43(5):680-5. PubMed ID: 7513109
    [Abstract] [Full Text] [Related]

  • 6. Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat.
    di Salle E, Giudici D, Biagini L, Cominato C, Briatico G, Panzeri A.
    J Steroid Biochem Mol Biol; 1995 Jun 15; 53(1-6):381-5. PubMed ID: 7626485
    [Abstract] [Full Text] [Related]

  • 7. Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy.
    Suzuki K, Okazaki H, Ono Y, Kurokawa K, Suzuki T, Onuma E, Takanashi H, Mamiya Y, Yamanaka H.
    Prostate; 1998 Oct 01; 37(2):70-6. PubMed ID: 9759700
    [Abstract] [Full Text] [Related]

  • 8. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
    Zhao XF, Yang Y, Wang W, Qiu Z, Zhang P, Wang B.
    Chin Med J (Engl); 2013 Feb 01; 126(4):711-5. PubMed ID: 23422194
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK, Ross M, Tate R, Chisholm GD.
    Clin Endocrinol (Oxf); 1997 Feb 01; 46(2):137-44. PubMed ID: 9135694
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS, Cai X, Abasolo I, Wang Z.
    Gene Expr; 2001 Feb 01; 9(4-5):183-94. PubMed ID: 11444528
    [Abstract] [Full Text] [Related]

  • 11. Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat.
    di Salle E, Giudici D, Briatico G, Ornati G, Panzeri A.
    J Steroid Biochem Mol Biol; 1993 Nov 01; 46(5):549-55. PubMed ID: 8240976
    [Abstract] [Full Text] [Related]

  • 12. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS.
    Prostate; 2004 Feb 01; 58(2):130-44. PubMed ID: 14716738
    [Abstract] [Full Text] [Related]

  • 13. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    Wright AS, Thomas LN, Douglas RC, Lazier CB, Rittmaster RS.
    J Clin Invest; 1996 Dec 01; 98(11):2558-63. PubMed ID: 8958218
    [Abstract] [Full Text] [Related]

  • 14. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI, Tanaka WK, Wang DZ, Ebel DL, Geissler LA, Dallob A, Hafkin B, Gertz BJ.
    J Clin Endocrinol Metab; 1997 May 01; 82(5):1373-7. PubMed ID: 9141518
    [Abstract] [Full Text] [Related]

  • 15. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G, Rittmaster RS, Klocker H.
    Eur Urol; 2000 Apr 01; 37(4):367-80. PubMed ID: 10765065
    [Abstract] [Full Text] [Related]

  • 16. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.
    Rittmaster RS, Magor KE, Manning AP, Norman RW, Lazier CB.
    Mol Endocrinol; 1991 Jul 01; 5(7):1023-9. PubMed ID: 1719382
    [Abstract] [Full Text] [Related]

  • 17. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor.
    di Salle E, Giudici D, Radice A, Zaccheo T, Ornati G, Nesi M, Panzeri A, Délos S, Martin PM.
    J Steroid Biochem Mol Biol; 1998 Feb 01; 64(3-4):179-86. PubMed ID: 9605412
    [Abstract] [Full Text] [Related]

  • 18. Effects of oral finasteride on erectile function in a rat model.
    Zhang MG, Wu W, Zhang CM, Wang XJ, Gao PJ, Lu YL, Shen ZJ.
    J Sex Med; 2012 May 01; 9(5):1328-36. PubMed ID: 22375859
    [Abstract] [Full Text] [Related]

  • 19. Androgens are not major down-regulators of androgen receptor levels during growth of the immature rat penis .
    Shen R, Lin MC, Sadeghi F, Swerdloff RS, Rajfer J, Gonzalez-Cadavid NF.
    J Steroid Biochem Mol Biol; 1996 Mar 01; 57(5-6):301-13. PubMed ID: 8639466
    [Abstract] [Full Text] [Related]

  • 20. Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins.
    Huynh H.
    Int J Oncol; 2002 Jun 01; 20(6):1297-303. PubMed ID: 12012013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.